| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 3.52e-05 | 23 | 165 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLCO4A1 SLC34A2 SLC7A6 SLCO1B7 SLC6A3 SLC12A1 SLC12A3 SLC12A9 SLC35D3 SLC9A7 SLC26A6 | 3.68e-05 | 296 | 165 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 ABCB5 SLCO4A1 SLC34A2 SLC7A6 SLCO1B7 SLC6A3 SLC12A1 SLC12A3 SLC12A9 SLC35D3 SLC9A7 ATP4B SLC26A6 | 4.39e-05 | 477 | 165 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 4.49e-05 | 9 | 165 | 3 | GO:0015379 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 5.83e-05 | 26 | 165 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 2.03e-04 | 3 | 165 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 2.03e-04 | 3 | 165 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 2.87e-04 | 16 | 165 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 3.46e-04 | 17 | 165 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | FAD binding | 4.72e-04 | 44 | 165 | 4 | GO:0071949 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 4.85e-04 | 167 | 165 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 4.87e-04 | 19 | 165 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP42 DOCK4 ARHGAP23 MYO9A TIAM2 SYNGAP1 PLEKHG6 USP6NL RASAL1 | 5.36e-04 | 279 | 165 | 9 | GO:0005096 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.59e-04 | 171 | 165 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | ATPase inhibitor activity | 9.96e-04 | 6 | 165 | 2 | GO:0042030 | |
| GeneOntologyMolecularFunction | ATPase regulator activity | 1.03e-03 | 54 | 165 | 4 | GO:0060590 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.10e-03 | 94 | 165 | 5 | GO:0050660 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.25e-03 | 26 | 165 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | cytochrome-b5 reductase activity, acting on NAD(P)H | 1.39e-03 | 7 | 165 | 2 | GO:0004128 | |
| GeneOntologyMolecularFunction | amidine-lyase activity | 1.39e-03 | 7 | 165 | 2 | GO:0016842 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.62e-03 | 151 | 165 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1F ABCC1 ABCB5 MFSD9 SLCO4A1 SLC34A2 SLC7A6 SLCO1B7 SLC6A3 SLC12A1 SLC12A3 SLC12A9 SLC35D3 KCNK1 SLC9A7 KCNN4 AP4M1 ATP4B SLC26A6 VDAC3 | 1.79e-03 | 1180 | 165 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | cobalt ion binding | 1.84e-03 | 8 | 165 | 2 | GO:0050897 | |
| GeneOntologyBiologicalProcess | neuron projection development | BOC CACNA1F KLHL1 FN1 KIF26A MYO9A TNC FAT3 LAMA2 APLP2 ZSWIM6 ADGRV1 TIAM2 MKS1 SEMA4C SYNGAP1 GRIP1 POSTN HMCN2 MAP1S TRIM32 CLMN P3H1 CSPG4 ACTL6B TNR DCLK1 RASAL1 | 1.04e-06 | 1285 | 164 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | BOC CACNA1F KLHL1 FN1 KIF26A MYO9A TNC FAT3 LAMA2 APLP2 ZSWIM6 ADGRV1 TIAM2 MKS1 SEMA4C SYNGAP1 GRIP1 POSTN HMCN2 MAP1S TRIM32 CLMN P3H1 CSPG4 ACTL6B GRIP2 TNR DCLK1 RASAL1 | 4.29e-06 | 1463 | 164 | 29 | GO:0048666 |
| GeneOntologyCellularComponent | platelet alpha granule | 9.87e-05 | 93 | 166 | 6 | GO:0031091 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 3.08e-04 | 17 | 166 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.33e-04 | 332 | 166 | 10 | GO:0005788 | |
| GeneOntologyCellularComponent | tenascin complex | 3.72e-04 | 4 | 166 | 2 | GO:0090733 | |
| MousePheno | abnormal heart left ventricle morphology | ADAMTS19 PNPLA2 ZMPSTE24 SYNM DSP ATAD5 OXA1L HMCN2 AARS2 AIFM1 KCNN4 FNIP1 TBX20 GAA | 7.10e-06 | 369 | 128 | 14 | MP:0003921 |
| MousePheno | abnormal axon radial sorting | 7.40e-06 | 5 | 128 | 3 | MP:0020452 | |
| Domain | NNMT/PNMT/TEMT_CS | 6.77e-07 | 3 | 165 | 3 | IPR025820 | |
| Domain | NNMT_TEMT_trans | 6.77e-07 | 3 | 165 | 3 | IPR000940 | |
| Domain | SAM_MT_NNMT_PNMT_TEMT | 6.77e-07 | 3 | 165 | 3 | PS51681 | |
| Domain | NNMT_PNMT_TEMT | 6.77e-07 | 3 | 165 | 3 | PF01234 | |
| Domain | NNMT_PNMT_TEMT | 6.77e-07 | 3 | 165 | 3 | PS01100 | |
| Domain | SLC12_C | 3.67e-05 | 8 | 165 | 3 | IPR018491 | |
| Domain | SLC12 | 3.67e-05 | 8 | 165 | 3 | PF03522 | |
| Domain | AA-permease/SLC12A_dom | 3.79e-05 | 22 | 165 | 4 | IPR004841 | |
| Domain | AA_permease | 3.79e-05 | 22 | 165 | 4 | PF00324 | |
| Domain | FNIP_N_dom | 7.76e-05 | 2 | 165 | 2 | IPR028084 | |
| Domain | FNIP_mid_dom | 7.76e-05 | 2 | 165 | 2 | IPR028085 | |
| Domain | FNIP_C_dom | 7.76e-05 | 2 | 165 | 2 | IPR028086 | |
| Domain | Pr_beta_C | 7.76e-05 | 2 | 165 | 2 | PF12465 | |
| Domain | FNIP_C | 7.76e-05 | 2 | 165 | 2 | PF14638 | |
| Domain | FNIP_M | 7.76e-05 | 2 | 165 | 2 | PF14637 | |
| Domain | FNIP_N | 7.76e-05 | 2 | 165 | 2 | PF14636 | |
| Domain | Factor_5/8 | 7.76e-05 | 2 | 165 | 2 | IPR024715 | |
| Domain | FNIP_fam | 7.76e-05 | 2 | 165 | 2 | IPR026156 | |
| Domain | Proteasome_bsu_C | 7.76e-05 | 2 | 165 | 2 | IPR024689 | |
| Domain | AA_permease_N | 2.31e-04 | 3 | 165 | 2 | IPR013612 | |
| Domain | AA_permease_N | 2.31e-04 | 3 | 165 | 2 | PF08403 | |
| Domain | FN3_dom | 5.50e-04 | 209 | 165 | 8 | IPR003961 | |
| Domain | Pyr_redox_2 | 5.91e-04 | 19 | 165 | 3 | PF07992 | |
| Domain | ConA-like_dom | 7.47e-04 | 219 | 165 | 8 | IPR013320 | |
| Domain | NADH-Cyt_B5_reductase | 7.62e-04 | 5 | 165 | 2 | IPR001834 | |
| Domain | Cu-oxidase_3 | 7.62e-04 | 5 | 165 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 7.62e-04 | 5 | 165 | 2 | PS00079 | |
| Domain | FAD_binding_6 | 7.62e-04 | 5 | 165 | 2 | PF00970 | |
| Domain | Cu_oxidase_CS | 7.62e-04 | 5 | 165 | 2 | IPR033138 | |
| Domain | OxRdtase_FAD-bd_dom | 7.62e-04 | 5 | 165 | 2 | IPR008333 | |
| Domain | Cu-oxidase_3 | 7.62e-04 | 5 | 165 | 2 | PF07732 | |
| Domain | Cupredoxin | 9.22e-04 | 22 | 165 | 3 | IPR008972 | |
| Domain | Rho_GTPase_activation_prot | 1.10e-03 | 88 | 165 | 5 | IPR008936 | |
| Domain | Cu_oxidase_Cu_BS | 1.14e-03 | 6 | 165 | 2 | IPR002355 | |
| Pathway | WP_METHYLATION_PATHWAYS | 6.32e-05 | 9 | 131 | 3 | M39493 | |
| Pathway | WP_METHYLATION | 6.32e-05 | 9 | 131 | 3 | MM15836 | |
| Pubmed | 4.88e-09 | 257 | 167 | 12 | 16335952 | ||
| Pubmed | FN1 ARHGAP23 MYO9A TNC VPS13C SORBS1 ADGRV1 GRIP1 SBF1 TRIM32 PAM PNPLA8 TNR VDAC3 | 2.44e-08 | 430 | 167 | 14 | 32581705 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ZMPSTE24 FN1 ACAT1 DSP VPS13C FUZ ADGRV1 TIAM2 GSR ADH6 SLC12A1 SLC12A3 RNPEP SLC12A9 P3H1 PKLR C5 AP4M1 GAA VDAC3 | 1.06e-07 | 1016 | 167 | 20 | 19056867 |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 10552930 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 12458226 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 34504132 | ||
| Pubmed | 1.49e-06 | 18 | 167 | 4 | 14730302 | ||
| Pubmed | DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport. | 2.88e-06 | 21 | 167 | 4 | 26529256 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | TACO1 ABCC1 FN1 ARHGAP23 DSP GSR LMF2 OXA1L AARS2 SBF1 AIFM1 P3H1 DHRS7 CSPG4 CYB5R3 PAM CERCAM CFAP44 CATSPERG USP6NL GAA | 6.90e-06 | 1451 | 167 | 21 | 30550785 |
| Pubmed | 7.19e-06 | 146 | 167 | 7 | 27068509 | ||
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 19323993 | ||
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 9882526 | ||
| Pubmed | Twist1 transcriptional targets in the developing atrio-ventricular canal of the mouse. | 1.74e-05 | 11 | 167 | 3 | 22815831 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 1.83e-05 | 67 | 167 | 5 | 21875946 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 26599105 | ||
| Pubmed | The molecular basis of factor V and VIII procofactor activation. | 2.29e-05 | 2 | 167 | 2 | 19765210 | |
| Pubmed | Tenascins and inflammation in disorders of the nervous system. | 2.29e-05 | 2 | 167 | 2 | 23269478 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 36925204 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 18509036 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28057741 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 23485472 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 20647710 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 9174609 | ||
| Pubmed | Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer. | 2.29e-05 | 2 | 167 | 2 | 31936272 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15735794 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28986537 | ||
| Pubmed | Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism. | 2.29e-05 | 2 | 167 | 2 | 17287628 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 31476380 | ||
| Pubmed | Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes. | 2.29e-05 | 2 | 167 | 2 | 25422309 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 32777343 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16262655 | ||
| Pubmed | Tenascins are associated with lipid rafts isolated from mouse brain. | 2.29e-05 | 2 | 167 | 2 | 12056833 | |
| Pubmed | Activated protein C has a regulatory role in factor VIII function. | 2.29e-05 | 2 | 167 | 2 | 33512448 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 35681468 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 14562021 | ||
| Pubmed | Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers. | 2.29e-05 | 2 | 167 | 2 | 11091190 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 23313574 | ||
| Pubmed | Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis. | 2.29e-05 | 2 | 167 | 2 | 20708078 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 19887451 | ||
| Pubmed | Binding of tenascin-C to soluble fibronectin and matrix fibrils. | 2.29e-05 | 2 | 167 | 2 | 7499434 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24126453 | ||
| Pubmed | Mice lacking GRIP1/2 show increased social interactions and enhanced phosphorylation at GluA2-S880. | 2.29e-05 | 2 | 167 | 2 | 28063882 | |
| Pubmed | Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. | 2.29e-05 | 2 | 167 | 2 | 30451798 | |
| Pubmed | Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. | 2.29e-05 | 2 | 167 | 2 | 32518264 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22613792 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 9482226 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24792713 | ||
| Pubmed | GRIP1 and 2 regulate activity-dependent AMPA receptor recycling via exocyst complex interactions. | 2.29e-05 | 2 | 167 | 2 | 20956289 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 37968800 | ||
| Pubmed | Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. | 2.29e-05 | 2 | 167 | 2 | 8900278 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 20232238 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 19459213 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16565160 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8021284 | ||
| Pubmed | 4.10e-05 | 40 | 167 | 4 | 19864314 | ||
| Pubmed | 4.74e-05 | 15 | 167 | 3 | 18802027 | ||
| Pubmed | FN1 SYNM DSP FUZ OAZ1 SORBS1 TM2D3 REV3L SYNGAP1 RBM22 MAP1S TRIM32 PDE4DIP CERCAM EXOC7 BACE2 LNX1 DCLK1 | 4.99e-05 | 1285 | 167 | 18 | 35914814 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.05e-05 | 135 | 167 | 6 | 28675934 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ABCC1 PSMB7 APLP2 SEMA4C LMF2 AARS2 SLC12A9 TRIM32 P3H1 DHRS7 UTP20 UMPS EXOC7 GAA VDAC3 | 5.33e-05 | 942 | 167 | 15 | 31073040 |
| Pubmed | 5.82e-05 | 16 | 167 | 3 | 36709857 | ||
| Pubmed | 5.82e-05 | 16 | 167 | 3 | 20978075 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 6.12e-05 | 86 | 167 | 5 | 28327460 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 16816365 | ||
| Pubmed | Dominance of intrinsic genetic factors in shaping the human immunoglobulin Vlambda repertoire. | 6.85e-05 | 3 | 167 | 2 | 10610771 | |
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 6.85e-05 | 3 | 167 | 2 | 7694605 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 20489157 | ||
| Pubmed | Factor V Leiden improves in vivo hemostasis in murine hemophilia models. | 6.85e-05 | 3 | 167 | 2 | 16359510 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 2440899 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 32886326 | ||
| Pubmed | GRIP1 is required for homeostatic regulation of AMPAR trafficking. | 6.85e-05 | 3 | 167 | 2 | 26216979 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 20456758 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 30113482 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 21131289 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 25592075 | ||
| Pubmed | Reduced extracellular space in the brain of tenascin-R- and HNK-1-sulphotransferase deficient mice. | 6.85e-05 | 3 | 167 | 2 | 16262627 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 23325410 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 2461951 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 22641663 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 21383172 | ||
| Pubmed | Microdissection is essential for gene expression analysis of irradiated rectal cancer tissues. | 6.85e-05 | 3 | 167 | 2 | 19724871 | |
| Pubmed | Isolation and characterization of fibronectin-alpha 1-microglobulin complex in rat plasma. | 6.85e-05 | 3 | 167 | 2 | 7519849 | |
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 6.85e-05 | 3 | 167 | 2 | 7687262 | |
| Pubmed | Interaction of syntenin-1 and the NG2 proteoglycan in migratory oligodendrocyte precursor cells. | 6.85e-05 | 3 | 167 | 2 | 18218632 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 22032085 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 12368162 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 7530141 | ||
| Pubmed | Serine 62 is a phosphorylation site in folliculin, the Birt-Hogg-Dubé gene product. | 6.85e-05 | 3 | 167 | 2 | 19914239 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 11564973 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 36514952 | ||
| Pubmed | Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation. | 6.85e-05 | 3 | 167 | 2 | 21774968 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 19129481 | ||
| Pubmed | Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. | 6.85e-05 | 3 | 167 | 2 | 27498393 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 28652369 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 20665215 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 33459596 | ||
| Pubmed | Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. | 6.85e-05 | 3 | 167 | 2 | 21490918 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 15999119 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 26129894 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 19020767 | ||
| Pubmed | TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. | 6.85e-05 | 3 | 167 | 2 | 1696875 | |
| Interaction | SLC6A4 interactions | A2M FN1 ARHGAP23 MYO9A TNC VPS13C SORBS1 ADGRV1 GRIP1 SBF1 TRIM32 PAM PNPLA8 TNR VDAC3 | 3.01e-06 | 437 | 164 | 15 | int:SLC6A4 |
| Cytoband | 15q24.2 | 2.17e-04 | 32 | 167 | 3 | 15q24.2 | |
| Cytoband | 7p14.3 | 3.63e-04 | 38 | 167 | 3 | 7p14.3 | |
| GeneFamily | Solute carriers | SLCO4A1 SLC34A2 SLC7A6 SLCO1B7 SLC6A3 SLC12A1 SLC12A3 SLC12A9 SLC35D3 SLC9A7 SLC26A6 | 3.43e-05 | 395 | 112 | 11 | 752 |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.82e-04 | 25 | 112 | 3 | 504 | |
| GeneFamily | Immunoglobulin like domain containing | 1.28e-03 | 193 | 112 | 6 | 594 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.33e-03 | 9 | 112 | 2 | 1234 | |
| GeneFamily | Patatin like phospholipase domain containing | 1.66e-03 | 10 | 112 | 2 | 466 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.66e-03 | 10 | 112 | 2 | 830 | |
| GeneFamily | Kelch like|BTB domain containing | 2.23e-03 | 42 | 112 | 3 | 617 | |
| GeneFamily | PDZ domain containing | 2.56e-03 | 152 | 112 | 5 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 3.20e-03 | 160 | 112 | 5 | 555 | |
| GeneFamily | Cadherin related | 4.87e-03 | 17 | 112 | 2 | 24 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 6.07e-03 | 19 | 112 | 2 | 50 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | ABCC1 PNKP FN1 MFSD9 APLP2 TM2D3 SLC7A6 SEMA4C SLC12A9 P3H1 DHRS7 CSPG4 KCNN4 PAM GAA | 2.60e-07 | 457 | 167 | 15 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | ABCC1 PNKP FN1 MFSD9 APLP2 TM2D3 SLC7A6 SEMA4C SLC12A9 P3H1 DHRS7 CSPG4 KCNN4 PAM GAA | 3.72e-07 | 470 | 167 | 15 | MM1053 |
| Coexpression | GSE11924_TH1_VS_TH2_CD4_TCELL_UP | 6.68e-07 | 200 | 167 | 10 | M3159 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.89e-05 | 86 | 167 | 6 | M39247 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | DOCK4 KLHL1 ARHGAP23 FAT3 MUC16 TM2D3 GRIP1 PDE4DIP TSPAN13 ACTL6B GRIP2 UBE2QL1 DCLK1 | 2.33e-05 | 506 | 167 | 13 | M39067 |
| Coexpression | LEE_BMP2_TARGETS_UP | DPYD DSP ASPG LAMA2 REV3L F5 TRIL DHRS7 KCNK1 CYB5R3 DCHS1 PAM BACE2 GAA PADI1 TLCD5 | 4.16e-05 | 780 | 167 | 16 | M2324 |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 4.49e-05 | 200 | 167 | 8 | M6655 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | ARHGAP42 BOC DOCK4 ADAMTS19 ZMPSTE24 MYO9A PPFIBP2 VPS13C REV3L GK5 SYNGAP1 DHRS7 SLC9A7 PAM CERCAM ADGRE5 KLHL8 BACE2 DCLK1 VDAC3 | 3.78e-06 | 804 | 163 | 20 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | ARHGAP42 BOC DOCK4 ADAMTS19 LCORL MYO9A FAT3 MUC16 REV3L GK5 SYNGAP1 POSTN TRIL DHRS7 SLC9A7 PAM ADGRE5 BACE2 DCLK1 | 4.29e-06 | 740 | 163 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | ARHGAP42 BOC DOCK4 ADAMTS19 MYO9A PPFIBP2 REV3L GK5 SYNGAP1 DHRS7 SLC9A7 PAM CERCAM ADGRE5 KLHL8 BACE2 CSPP1 DCLK1 VDAC3 | 1.36e-05 | 803 | 163 | 19 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | DOCK4 ABCC1 DSP MYO9A MUC16 REV3L GK5 F8 SYNGAP1 P3H1 DHRS7 SLC9A7 CERCAM ADGRE5 KLHL8 CSPP1 DCLK1 VDAC3 | 3.88e-05 | 791 | 163 | 18 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | DOCK4 ADAMTS19 MYO9A REV3L GK5 SYNGAP1 DHRS7 PAM ADGRE5 KLHL8 BACE2 DCLK1 | 8.85e-05 | 414 | 163 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | ARHGAP42 BOC DOCK4 ADAMTS19 MYO9A GK5 DHRS7 SLC9A7 ADGRE5 KLHL8 BACE2 DCLK1 | 1.06e-04 | 422 | 163 | 12 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | DOCK4 ADAMTS19 MYO9A REV3L GK5 SYNGAP1 DHRS7 PAM BACE2 DCLK1 | 1.15e-04 | 301 | 163 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000 |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 2.83e-09 | 190 | 167 | 10 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-09 | 190 | 167 | 10 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.32e-08 | 194 | 167 | 9 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | DSP RASSF10 SLC34A2 ADGRV1 GRIP1 FGF20 KCNK1 TSPAN13 MAP3K21 | 5.56e-08 | 195 | 167 | 9 | ce1ba5911e8a6ddb07434acc37147c38e94245ff |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.81e-08 | 196 | 167 | 9 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | DSP RASSF10 SLC34A2 ADGRV1 GRIP1 FGF20 KCNK1 TSPAN13 MAP3K21 | 6.07e-08 | 197 | 167 | 9 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | DSP RASSF10 SLC34A2 ADGRV1 GRIP1 FGF20 KCNK1 TSPAN13 MAP3K21 | 6.34e-08 | 198 | 167 | 9 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.34e-08 | 198 | 167 | 9 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.91e-08 | 200 | 167 | 9 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.91e-08 | 200 | 167 | 9 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.91e-08 | 200 | 167 | 9 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-07 | 170 | 167 | 8 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-07 | 173 | 167 | 8 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-07 | 175 | 167 | 8 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.80e-07 | 178 | 167 | 8 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.69e-07 | 183 | 167 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 4.69e-07 | 183 | 167 | 8 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 191 | 167 | 8 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-07 | 191 | 167 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 191 | 167 | 8 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 191 | 167 | 8 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-07 | 191 | 167 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.74e-07 | 192 | 167 | 8 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-07 | 193 | 167 | 8 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-07 | 193 | 167 | 8 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 194 | 167 | 8 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.29e-07 | 194 | 167 | 8 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 194 | 167 | 8 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-07 | 195 | 167 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-07 | 195 | 167 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.58e-07 | 195 | 167 | 8 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.88e-07 | 196 | 167 | 8 | 75e9e430a4f55ef10f2e3132afa690fc8bfaff83 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-07 | 196 | 167 | 8 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.88e-07 | 196 | 167 | 8 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.88e-07 | 196 | 167 | 8 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.88e-07 | 196 | 167 | 8 | 00bef0e47739932fd1da109cd607de0789d14ca5 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.88e-07 | 196 | 167 | 8 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.18e-07 | 197 | 167 | 8 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.18e-07 | 197 | 167 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.50e-07 | 198 | 167 | 8 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-07 | 199 | 167 | 8 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-07 | 199 | 167 | 8 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-07 | 199 | 167 | 8 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-07 | 199 | 167 | 8 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-07 | 199 | 167 | 8 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-07 | 199 | 167 | 8 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-07 | 199 | 167 | 8 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.17e-07 | 200 | 167 | 8 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.17e-07 | 200 | 167 | 8 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | 5'-Airway_Nasal-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.17e-07 | 200 | 167 | 8 | 358d71329921451c7f5a56f1db0f9989af2299dc | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | 5'-Airway_Nasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.17e-07 | 200 | 167 | 8 | f6e967738b4f7b173d6e9977e305f77380dd6c8a | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.17e-07 | 200 | 167 | 8 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.17e-07 | 200 | 167 | 8 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 356C-Fibroblasts|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.17e-07 | 200 | 167 | 8 | 9c95329f0b26ff378de803030d4c28517b3adc85 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.17e-07 | 200 | 167 | 8 | b68d212159b9d04866ba02ff55c35be247805eec | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 9.17e-07 | 200 | 167 | 8 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.17e-07 | 200 | 167 | 8 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 160 | 167 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 160 | 167 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-06 | 168 | 167 | 7 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-06 | 168 | 167 | 7 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.56e-06 | 169 | 167 | 7 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-06 | 174 | 167 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.20e-06 | 179 | 167 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 5.20e-06 | 179 | 167 | 7 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 5.59e-06 | 181 | 167 | 7 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.80e-06 | 182 | 167 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.80e-06 | 182 | 167 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 183 | 167 | 7 | 63294d66e3ccf152ffe5d1237106764c14390b62 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.01e-06 | 183 | 167 | 7 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 183 | 167 | 7 | 7e5c467fd1b156b928f1611a12ab4affb9f714b7 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.01e-06 | 183 | 167 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.15e-06 | 69 | 167 | 5 | 0862e6c8d8af4310b9a1f0879e51ee25115b26b1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.15e-06 | 69 | 167 | 5 | d2ff9cea216122d697822cdd2eecbce8f557728d | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 6.45e-06 | 185 | 167 | 7 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-06 | 185 | 167 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.45e-06 | 185 | 167 | 7 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.92e-06 | 187 | 167 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 187 | 167 | 7 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.92e-06 | 187 | 167 | 7 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 187 | 167 | 7 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 187 | 167 | 7 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.17e-06 | 188 | 167 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-06 | 188 | 167 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.42e-06 | 189 | 167 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.68e-06 | 190 | 167 | 7 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 191 | 167 | 7 | 9431ffd6b758f756609d9057de2023596e22b5d4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 191 | 167 | 7 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 191 | 167 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.95e-06 | 191 | 167 | 7 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 191 | 167 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.95e-06 | 191 | 167 | 7 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 8.13e-06 | 73 | 167 | 5 | 116259a036373bccaeb77fe3c675741a5ca81c52 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.22e-06 | 192 | 167 | 7 | 8898332387e5d746feb346ce1dabd6b2218fc6e5 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.22e-06 | 192 | 167 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.50e-06 | 193 | 167 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| Drug | bumetanide | DPYD PSMB10 SLC34A2 GSR SLC6A3 SLC12A1 SLC12A3 ACTL8 SLC12A9 SLC9A7 KCNN4 ACTL6B | 4.31e-08 | 209 | 165 | 12 | CID000002471 |
| Drug | tetrahydroisoquinoline | 3.18e-06 | 56 | 165 | 6 | CID000007046 | |
| Drug | diphenyl disulfide | 7.52e-06 | 18 | 165 | 4 | CID000013436 | |
| Drug | Flavin-Adenine Dinucleotide | 7.52e-06 | 18 | 165 | 4 | DB03147 | |
| Drug | 0ZI | 1.18e-05 | 20 | 165 | 4 | CID000122235 | |
| Disease | unipolar depression, multiple sclerosis | 3.32e-05 | 12 | 160 | 3 | EFO_0003761, MONDO_0005301 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 1.01e-04 | 17 | 160 | 3 | EFO_0800030 | |
| Disease | asparagine measurement, amino acid measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0005134, EFO_0009766 | |
| Disease | guanylyl cyclase-activating protein 1 measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0801663 | |
| Disease | Cis-4-decenoyl carnitine measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0022091 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 6.03e-04 | 7 | 160 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | ABCC1 DPYD KLHL1 ASPG TM2D3 REV3L SLC7A6 PTPRT MROH1 CLMN CYB5R3 UMPS MDGA1 LNX1 | 6.63e-04 | 945 | 160 | 14 | EFO_0005653 |
| Disease | cerebellar ataxia (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 8.20e-04 | 277 | 160 | 7 | C0009404 | |
| Disease | octanoylcarnitine measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0021042 | |
| Disease | macrovascular complications of diabetes | 1.28e-03 | 10 | 160 | 2 | EFO_0010977 | |
| Disease | Charcot-Marie-Tooth disease | 1.54e-03 | 42 | 160 | 3 | cv:C0007959 | |
| Disease | Enzymopathy | 1.56e-03 | 11 | 160 | 2 | C0520572 | |
| Disease | Colorectal Carcinoma | 1.62e-03 | 702 | 160 | 11 | C0009402 | |
| Disease | glutaroyl carnitine measurement | 2.19e-03 | 13 | 160 | 2 | EFO_0021005 | |
| Disease | vascular brain injury measurement, vascular brain injury | 2.19e-03 | 13 | 160 | 2 | EFO_0006791, EFO_0006800 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.19e-03 | 13 | 160 | 2 | cv:C4082197 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 2.55e-03 | 14 | 160 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Meckel-Gruber syndrome | 2.93e-03 | 15 | 160 | 2 | C0265215 | |
| Disease | high grade glioma (biomarker_via_orthology) | 2.93e-03 | 15 | 160 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 2.98e-03 | 109 | 160 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 2.98e-03 | 109 | 160 | 4 | C0000786 | |
| Disease | Miscarriage | 2.98e-03 | 109 | 160 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 2.98e-03 | 109 | 160 | 4 | C0000822 | |
| Disease | Peripheral Nervous System Diseases | 3.17e-03 | 54 | 160 | 3 | C4721453 | |
| Disease | metabolite measurement | 3.61e-03 | 560 | 160 | 9 | EFO_0004725 | |
| Disease | venous thromboembolism | 3.74e-03 | 460 | 160 | 8 | EFO_0004286 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.77e-03 | 17 | 160 | 2 | C2936862 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.77e-03 | 17 | 160 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Polydactyly | 3.84e-03 | 117 | 160 | 4 | C0152427 | |
| Disease | blood nickel measurement | 4.20e-03 | 120 | 160 | 4 | EFO_0007583 | |
| Disease | Meckel syndrome type 1 | 4.22e-03 | 18 | 160 | 2 | C3714506 | |
| Disease | essential hypertension (is_implicated_in) | 4.22e-03 | 18 | 160 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | Bardet-Biedl syndrome | 4.22e-03 | 18 | 160 | 2 | cv:C0752166 | |
| Disease | diet measurement, HOMA-B | 4.70e-03 | 19 | 160 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | acylcarnitine measurement | 5.13e-03 | 127 | 160 | 4 | EFO_0005059 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLIGLGYTQTLRPGV | 241 | Q9Y277 | |
| SGGGVLEERPLTLYR | 1406 | Q96QE3 | |
| YVLLVVGGGPTLDSL | 946 | Q6ZRH7 | |
| GGSLVLGGIEPSLYK | 246 | Q9Y5Z0 | |
| SLPLISIVGYVDGGI | 136 | Q6UXE8 | |
| PTLSYIGGGILSQDR | 386 | Q5FYA8 | |
| LQVLLTYRVGEGPGV | 136 | Q9H4A4 | |
| GVLSYLEPRGSLLLG | 311 | Q6UVK1 | |
| LGPDVGYEAIGLVDS | 486 | O95831 | |
| LLYPTILGHEGAGIV | 61 | P28332 | |
| GLLTGVVVDSGYGLT | 141 | Q9H568 | |
| SLILNGEPGYTIGTV | 311 | Q2M3G0 | |
| DIRPGLYGSVIVTGG | 336 | O94805 | |
| PGRSVIVGAGYIAVE | 231 | P00390 | |
| GVPLLIVGVSAAIYS | 661 | P48960 | |
| SLVRGPGILGEVTVF | 4176 | Q8WXG9 | |
| GVYLLPGQVSGVALD | 506 | P19021 | |
| TYGGVSGTAIRPIAL | 761 | Q12882 | |
| GAEREYGGIIPISLP | 61 | Q8N865 | |
| GLRTELATYPGIIVS | 216 | Q9Y394 | |
| GVTLRPDVYGEKGLE | 81 | P51164 | |
| IYLRSSSGEGIGVIG | 176 | Q96MT7 | |
| EAEGLGYVDVGLIPA | 706 | Q9UKP4 | |
| GYVDVGLIPAGAREI | 711 | Q9UKP4 | |
| LIYAVLPTGDVIGDS | 541 | P01023 | |
| LRGYGPGIRVDEVSF | 241 | O00189 | |
| TYLVGAGIELDGSRP | 276 | A6NK89 | |
| SLGLLTGYLGPIVDA | 411 | O95294 | |
| TGYLGPIVDAIVGSV | 416 | O95294 | |
| PEDKTITTLYVGGLG | 226 | Q9NW64 | |
| IGDTIEFRGPSGLLV | 136 | P00387 | |
| GGTEYPLGRILIGSS | 421 | Q9ULC6 | |
| GGLPYELTEGDIICV | 41 | Q9Y388 | |
| GAGYVEVLVIPAGAR | 801 | Q8TE59 | |
| TREGGPLLYEGISLT | 446 | Q32P28 | |
| LVLGGVDVTGPHLYS | 141 | Q99436 | |
| VGLTAPALALAGYIE | 21 | Q06481 | |
| RGPGYLGDIAIDDVT | 896 | Q8NFP4 | |
| PLLLVEEGAAGEGYL | 1851 | O60840 | |
| PIGKGYITEGRLDTS | 1041 | Q8WXI7 | |
| GLLLPGAGATLYREE | 3096 | Q96JQ0 | |
| GVRYVDGGISDNLPL | 161 | Q96AD5 | |
| LYGAGPSDSGTRVLI | 101 | Q8WUE5 | |
| RIPVSLLYSGLAIGG | 31 | Q9GZN0 | |
| SPGLLTYVLEELERG | 26 | Q66K74 | |
| ITFLTIGYGDVVPGT | 246 | O15554 | |
| ILGPVVGGYLTELED | 181 | Q8NBP5 | |
| VRVPLYTLRDGVGGL | 141 | Q96DE0 | |
| YTLRDGVGGLPTFLE | 146 | Q96DE0 | |
| GDTLIDIGSGPTIYQ | 56 | O95050 | |
| GPERRLLAVYTGGTI | 6 | Q86U10 | |
| PQLYVSGELIGGLDI | 201 | O76003 | |
| LLRVSGVSYSGVAPG | 411 | Q8NDA2 | |
| LEISGIIPTDGGRYQ | 571 | Q8NDA2 | |
| RLDVYVPPTIEGAGG | 1616 | Q8NDA2 | |
| ISLSTIGLGDYVPGE | 221 | O00180 | |
| VGFESILEGLYGPRL | 51 | Q8N3X6 | |
| LGDFGLATIVDGPLY | 531 | O15075 | |
| YVAALTTPRGGVGIA | 536 | Q9P2G9 | |
| ALDGVILGDYLSRTP | 276 | Q96PD5 | |
| GDLLIDIGSGPTIYQ | 56 | P40261 | |
| SLGIDYGLSLPLGED | 101 | Q1MSJ5 | |
| YVISVEPGGVISRDG | 536 | Q8TBB1 | |
| VPVGGRIYIDDGLIS | 211 | P30613 | |
| IYVGPGGAALSDREL | 791 | Q9ULI4 | |
| LPGSGRLVEGEVYAV | 56 | Q9BVM4 | |
| GSGVGRVEYPDLTID | 2211 | P24043 | |
| GILGPLLYGEVGDTL | 466 | P00451 | |
| TPLTVYAGAGSRVGL | 266 | P18627 | |
| PGLGRYLEVLIGVSV | 436 | O75022 | |
| FAELGLGSYTPVGLI | 111 | Q15070 | |
| GRLLVVSSSPYLGDG | 541 | Q8NDA8 | |
| RTVLSGGSLYIEIPG | 131 | P54368 | |
| TTIIPAGGAGYKVLA | 261 | Q9NX62 | |
| IREGPTGRLEEYLGS | 101 | Q9UPT5 | |
| GLGEEGLLSRLYEEP | 511 | Q9UHF4 | |
| GGLIILEPRFTGDTL | 746 | Q8ND30 | |
| GEDGLILTPLGRYQI | 701 | Q9NXE4 | |
| GVYLQEGPVGSTLSL | 1711 | O95248 | |
| YEIRVLLTRPGEGGT | 356 | O14522 | |
| PLQGLVASRIETYGG | 11 | Q3KR16 | |
| LLRTYAGGAVIPTGT | 226 | P0CG42 | |
| LEGEGSVLKRGPYGT | 496 | Q9NZI5 | |
| SDLPYLIVGVVLGSI | 851 | Q9BWV1 | |
| SFRGTVPYGLSLEIG | 16 | Q8N1I0 | |
| RLGPGGLDPVEVYES | 286 | Q16543 | |
| GSIVVSGLTPGVEYV | 1136 | P02751 | |
| IGYRITVVAAGEGIP | 1296 | P02751 | |
| LGDLYGAIGSPVRLA | 506 | Q8TF40 | |
| AQLGDLYGAIGSPVR | 486 | Q9P278 | |
| GAVPIGASIYVIGDL | 521 | Q9H2C0 | |
| GVTLDPRGIYGTISR | 941 | P01031 | |
| YLTGGLVDPEVHGRI | 2731 | P15924 | |
| TSPEGQGIIYIIIDG | 2211 | Q8TDW7 | |
| RSTGGILDVYIFLGP | 331 | P10253 | |
| GYAIVRRPTVGIGGD | 36 | Q5JVL4 | |
| RYPGFVLGLDVGSSV | 16 | Q6ZS86 | |
| VLLGVRAVPSLGYTE | 241 | Q5BKX5 | |
| TLLSVTGEVEPRGYL | 341 | Q9H0L4 | |
| ETAVEGLPGLVVAGY | 456 | Q5T4B2 | |
| LKRYGGPLGITISGT | 676 | Q9Y3R0 | |
| RYGGPLGITISGTEE | 661 | Q9C0E4 | |
| ETEGTLILLFGGIPY | 86 | O75844 | |
| LPDSGVVEYLSTGGV | 416 | Q9ULM6 | |
| YLVLGTEEPGTGVRL | 366 | Q9BT04 | |
| VYTAGLRGGLTPEET | 56 | A6NK58 | |
| DGGEPVRSGTLRIYI | 216 | Q9Y5H4 | |
| GLIVRGYRQPLEGSD | 226 | P33527 | |
| GGVGYLSRGDPVRVL | 531 | O43189 | |
| LSRPTEGVQALVGGY | 291 | Q9NP80 | |
| GLVSIRGVDSGLYLG | 106 | Q9NP95 | |
| LTDPGDIRTGTKGYL | 186 | Q2WGJ9 | |
| YPGIAENIGESITIG | 1281 | O75691 | |
| LTGDPIGYVTGVLAV | 151 | Q5M8T2 | |
| GGYSVLIREGLTCPV | 606 | Q13049 | |
| IFDPLRYLVGASGGV | 176 | Q9NX52 | |
| RELYIPSGESEVAGG | 1071 | O15061 | |
| TISGLLGPTLYAEVG | 81 | P12259 | |
| LGGRPEVVLEGSYDG | 461 | Q9BU23 | |
| ELLTGEVPYRGIDGL | 336 | Q5TCX8 | |
| ETRGITILGLYRIGG | 406 | A6NI28 | |
| TILVGGRYVTVLLDP | 66 | Q16647 | |
| LLYEGRGPGGSSLLI | 136 | Q9BSH4 | |
| PGELLTLIGATGISY | 296 | Q9BXS9 | |
| YLISRSLGPEFGGSI | 246 | Q13621 | |
| GSTPYGGVKLEDLIV | 166 | P24752 | |
| PGLEGSLGVGDTLYL | 81 | Q96T60 | |
| SLIVGGVDLTGPQLY | 136 | P40306 | |
| GGILVPIYFGALIDT | 536 | G3V0H7 | |
| LTLTEPTGLLYVGAR | 56 | Q9C0C4 | |
| GDVVEFRGPSGLLTY | 141 | Q9UHQ9 | |
| YDLAGGVGAPQLVEL | 226 | Q5JTZ9 | |
| LHGVGATPLYTLGVT | 236 | Q96BD0 | |
| PYVALLITARGGHIG | 346 | Q96SE0 | |
| QVLYLSRGGVGTTPA | 796 | Q96JQ2 | |
| IGVITIERAYPLTLG | 446 | O95436 | |
| EFLGGLSPGVLDRLY | 21 | Q92759 | |
| SGRTLIDIGSGPTVY | 71 | P11086 | |
| AGAGVGYALLVIVTP | 16 | Q6UW78 | |
| LSIGLSAYIGFIDGP | 46 | Q6ZRR5 | |
| RVVLPVLSGGYVLGG | 286 | Q8WVN8 | |
| GSQVIIIAGPGYDAL | 316 | Q96CK0 | |
| IIAGPGYDALTAEGI | 321 | Q96CK0 | |
| SRIEVLPVDTGAGGY | 696 | Q92738 | |
| VLSPRLENGYVLDGG | 71 | A1L167 | |
| PIIGEYAGEVLRFVG | 156 | O95857 | |
| ISDVLPDGLAYGEGL | 921 | Q8IVF5 | |
| GGSLELEDLSYVRIP | 451 | Q9NXB0 | |
| YQTPLLIRSGITGLE | 2361 | O60673 | |
| GYVGLVTVPVATLAG | 341 | Q96PV0 | |
| EARGLESTGIYRVPG | 931 | Q9P227 | |
| TLPGAIDGIRAYLSV | 286 | Q01959 | |
| YRLLGEEGVALPANG | 11 | Q9BXP2 | |
| IYKSVLEGGDIPLQG | 681 | Q9BX66 | |
| LVTLPEAGSRGGVDY | 681 | Q7L0X0 | |
| TLTGLRPGTEYGIGV | 951 | P24821 | |
| ATLTDLVPGTEYGVG | 651 | Q92752 | |
| GLSSPIYIDLRGIVS | 31 | P11172 | |
| GGTYFLISRSLGPEL | 201 | P55017 | |
| ATLEGLYLLVVPGAS | 81 | Q709C8 | |
| PRRVGIALDYEGGTV | 486 | Q12899 | |
| SSLLPGVLLGYEIVD | 86 | Q8TE23 | |
| SLIGIGIALSGVPFY | 451 | Q92536 | |
| LLEAGPYSGLGEIIH | 746 | Q9HCJ5 | |
| RSPIRTYGGEEDVLG | 311 | Q9UMR3 | |
| PTLGGEEGVSRIYAD | 41 | Q9Y5Q8 | |
| LPIDHVYGTLGIVGA | 96 | Q15063 | |
| IVGVILRYGTPATSG | 111 | Q96T83 | |
| LYLLGAGPVEAGVTQ | 11 | A0A0A0MS03 | |
| GLGGLTVYSLGEIIT | 186 | Q3YBR2 | |
| TLIDVLLIGVGYVGP | 226 | Q9BRN9 | |
| LLIGVGYVGPADGSL | 231 | Q9BRN9 | |
| LGVTVLEGPIYAVGG | 546 | Q9NR64 | |
| GVYSGPIGTAILIIA | 116 | A6NI61 | |
| PEVGLVNIKGYGSLE | 1171 | B2RTY4 | |
| RGTIELGRILEPGYL | 1791 | Q5VU43 | |
| PTRYGVVLGAVIGGV | 151 | P25189 |